UI Hospitals and Clinics

Clinical Trial Details

Short Title
Official Title
Insulin Resistance Intervention after Stroke (IRIS)
  • Purpose: is to test the effectiveness of a new medication called pioglitazone for preventing future strokes and heart attacks among persons with a recent stroke or TIA.
  • Eligibility: persons 40 years of age or older who have had a stroke or TIA in the past 6 months and are not diabetic are eligible.
  • Duration and Involvement: patients will be asked to take the study medication daily (pioglitazone 45 mg vs. placebo) and return to clinic once per year for study visits. Participation will last approximately 5 years.
Start Date
August 31, 2012
End Date
February 28, 2013
Gender Preference
Age Group
40 - 99 years
Principal Investigator
Enrique Leira, MD
Contact Info

Jeri Sieren, RN at 319-356-8744

IRIS study ; Neurology ;

We welcome your feedback! Please help us improve your experience on our website by completing a brief survey.